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A B S T R A C T
Hyperelodiones A-C, three undescribed monoterpenoid polyprenylated acylphloroglucinols possessing 6/6/6
fused tricyclic core, were isolated from Hypericum elodeoides Choisy. Their gross structures were elucidated by
HRESIMS and NMR data. The absolute configurations of hyperelodiones A-C were assigned by their calculated
and compared electronic circular dichroism (ECD) spectra combined with their common biosynthetic origin. A
fluorescence quenching assay suggested that hyperelodiones A-C could bind to RXRα-LBD, whereas hyper-
elodione C showed the strongest interaction with a KD of 12.81 μΜ. In addition, hyperelodiones A-C dose-
dependently inhibited RXRα transactivation and the growth of HeLa and MCF-7 cells. Among them, hyper-
elodione C showed the most potent inhibitory activities and dose-dependent PARP cleavage. Molecular docking
results suggested that hyperelodione C showed a different interaction mode compared with hyperelodione A and
hyperelodione B. Thus, hyperelodione C can be considered as a promising lead compound for cancer therapy,
which can bind to RXRα-LBD and induce HeLa and MCF-7 cell apoptosis.
1. Introduction
Polycyclic polyprenylated acylphloroglucinols (PPAPs) are a class of
structurally fascinating natural products that possess highly oxygenated
acylphloroglucinol-derived cores. Prenylation of this core moiety af-
fords monocyclic polyprenylated acylphloroglucinols (MPAPs), which
are further cyclized to various types of PPAP metabolites (Ciochina and
Grossman, 2006). Monoterpenoid polyprenylated acylphloroglucinols,
generally decorated with a geranyl or a cyclic monoterpene fragment at
C-3 of the phloroglucinol ring are ascribed to the MPAP family (Li et al.,
2019). Apart from their intriguing chemical structures, PPAPs have
been reported to show diverse activities, such as anticancer, anti-in-
flammatory, anti-HIV, antiplasmodial, and antimicrobial activities
(Decosterd et al., 1989; Fobofou et al., 2015; Yang et al., 2015; Zhang
et al., 2015; Zhu et al., 2015). However, the mechanism of action of
PPAPs still need further investigation. The retinoid X receptor α
(RXRα), a ligand-dependent transcriptional factor, has multiple phy-
siological functions including cell proliferation, differentiation, and
apoptosis (Robinsonrechavi et al., 2003). RXRα is an ideal drug target
for cancer therapy, and its ligand Targretin has been approved by the
FDA for the treatment of cutaneous T-cell lymphoma (Lenhard et al.,
1999). Our previous research has shown that several PPAPs exhibit
RXRα transcriptional inhibitory activities, while some PPAPs have
shown a direct interaction with the ligand-binding domain (LBD) of
RXRα (Tian et al., 2014a, 2014c, 2016, 2017a, 2017b).
The majority of PPAPs have been reported to be isolated from the
plants of family Guttiferae (Clusiaceae), especially from the genera
Hypericum and Garcinia (Yang et al., 2018). To identify more un-
described PPAPs as small-molecule regulators of RXRα, a phytochem-
ical study of Hypericum elodeoides Choisy was carried out. As a result,
three undescribed monoterpenoid polyprenylated acylphloroglucinols
(1–3) possessing 6/6/6 fused tricyclic core were obtained, of which 3
could bind to RXRα-LBD and induce HeLa and MCF-7 cell apoptosis.
The monoterpenoid fragments in 1–3 have been predicted to be bio-
synthesized by an isopentenyl at C-3, forming a dihydropyran ring with
the 4-OH of the core structure, with another lateral prenyl group lo-
cated at C-8 cyclizing into a six-membered ring by a carbon–carbon
bond formation between C-5 and C-7, which is quite different from the
reported monoterpenoid polyprenylated acylphloroglucinols cyclized
by a geranyl group (two prenyl groups linked from head to tail) at C-3.
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In this paper, the isolation, structural elucidation and biological activity
evaluation of these three undescribed monoterpenoid polyprenylated
acylphloroglucinols (1–3) will be reported.
2. Results and discussion
2.1. Isolation and structural elucidation
The dried whole plants of H. elodeoides (12.9 kg) were extracted
exhaustively with 95% aqueous EtOH and partitioned consecutively
with petroleum ether. The fluorescence quenching assay suggested that
the EtOH and petroleum ether extracts could bind to RXRα with a KD
values of 56.37 μΜ and 42.09 μΜ, respectively (supporting informa-
tion). Thus, the petroleum ether extract was further studied to identify
the small-molecule regulators of RXRα. As a result, through various
column chromatography and reversed-phase HPLC procedures, three
undescribed active compounds (1–3) were obtained (Fig. 1).
Hyperelodione A (1) was obtained as a yellowish oil and assigned
the molecular formula C26H36O4 on the basis of the HRESIMS [M+H]+
ion at m/z 413.2695 [M+H]+ (calcd. for C26H37O4, 413.2686), cor-
responding to nine indices of hydrogen deficiency. The IR (1651 cm−1
and 3581 cm-1) spectrum indicated the presence of carbonyl and hy-
droxyl groups. The 13C NMR and DEPT-135 data of compound 1
(Table 1) showed 26 carbon signals, including an isopropyl group [δC
35.4 (C-2′), 19.0 (C-3′), 19.4 (C-4′)], an isopentenyl group [δC 35.7 (C-
17), 120.3 (C-18), 133.6 (C-19), 25.9 (C-20), 18.3 (C-21)], an enol-β-
triketone group [δC 106.2 (C-1), 190.1 (C-2), 196.4 (C-6), and 207.2 (C-
1′)], an enol group [δC 170.3 (C-4), 107.9 (C-3)], together with two
olefinic carbons [δC 134.9 (C-14), 121.6 (C-15)], four methyls [δC 25.83
(Me-10), 25.1 (Me-11), 23.8 (Me-16), 25.78 (Me-22)], two methylenes
[δC 19.9 (C-12), 30.1 (C-13)], two methines [δC 30.3 (C-7), 40.0 (C-8)]
and one quaternary carbon [δC 80.0 (C-9)], which accounted for six
indices of hydrogen deficiency. The remaining three indices of hy-
drogen deficiency required tricyclic structure in 1. The above analyses
implied that 1 was a derivative of acylphloroglucinol. In the HMBC
spectrum, the correlations from the active proton of OH-2 (δH 19.34) to
C-1 (δc 106.2), C-2 (δc 190.1), C-1′ (δc 207.2), and C-2′ (δc 35.4)
confirmed the existence of the enol-β-triketone group and located the
position of the OH group at C-2. It also indicated that a pseudo six-
membered heterocyclic ring was formed due to strong intramolecular
hydrogen bonding between the active hydrogen and O-2′.
The correlations from δH 1.25 (H3-22) to δC 170.2 (C-4), 53.1 (C-5),
and 196.5 (C-6), together with those from δH 3.28 (H-7) to δC 107.9 (C-
3) and 170.2 (C-4) indicated the linkage of C3/C4/C5/C6. In addition,
the HMBC correlations from δH 1.11 (Me-3′)/1.17 (Me-4′) to δC 35.4 (C-
2′) and 207.2 (C-1′) suggested that isopropyl group was linked to C-1′ of
the enol-β-triketone group. Thus, a methylated acylphloroglucinol core
was deduced. Furthermore, the HMBC correlations from δH 2.71, 2.49
(H2-17) to C-5, C-18, and C-19 suggested the linkage of isoprenyl
groups to C-5 of the core structure. In addition, the 1H–1H COSY cor-
relations of δH 6.09 (H-15)/3.28 (H-7), δH 3.28 (H-7)/1.67 (H-8), δH
1.67 (H-8)/1.25 (Ha-12), and δH 1.25 (Ha-12)/1.98, 1.89 (H2-13)
showed a long spin system arising from the C-15 − C-7 − C-8 − C-12
partial structure. Combined with the HMBC correlations from H-7 to C-
3/C-6/C-4/C-8/C-12, H-8 to C-3/C-15, H3-10/H3-11 to C-9, H2-13 to C-
8/C-14/C-15, and H3-16 to C-13/C-14/C-15 indicated that an iso-
pentenyl at C-3 formed a dihydropyran ring with the 4-OH of the core
structure and another lateral prenyl group located at C-8 cyclized to
form a six-membered ring by a carbon–carbon bond formed between C-
15 and C-7 (Fig. 2). Hence, the 2D structure of 1 was deduced.
In the NOESY spectrum of 1, the correlations between δH 3.28 (H-7)
and 1.26 (H3-11) indicated that H-7 and Me-11 were located at the axial
position with the same orientation. In addition, the NOESY correlations
of δH 1.67 (H-8)/1.26 (H3-11), and δH 1.67 (H-8)/1.40 (H3-10) further
suggested that the cyclohexene moiety was cis-fused with the dihy-
dropyran ring. Moreover, the NOESY correlations of δH 1.40 (H3-10)/
Fig. 1. Structure of compounds 1–3.
Table 1
NMR spectroscopic data for 1–3 (600 MHz, CDCl3).
No. 1 2 3
δC, type δH (J in
Hz)
δC, type δH (J in
Hz)
δC, type δH (J in
Hz)
1 106.2, C 106.7, C 107.2, C
2 190.1, C 190.2, C 189.9, C
3 107.9, C 107.9, C 107.8, C
4 170.3, C 170.2, C 170.4, C
5 53.2, C 53.1, C 53.0, C
6 196.4, C 196.5, C 196.6, C
7 30.3, CH 3.28, br.s 30.3, CH 3.28, br.s 30.3, CH 3.28, br.s
8 40.0, CH 1.67, m 40.0, CH 1.68, m 40.0, CH 1.66, m
9 80.0, C 80.0, C 80.0, C
10 25.83, CH3 1.40, s 25.75, CH3 1.40, s 25.84, CH3 1.41, s
11 25.1, CH3 1.26, s 25.2, CH3 1.26, s 25.1, CH3 1.27, s
12 19.9, CH2 1.80, m
1.25, m
20.0, CH2 1.81, m
1.26, m
19.9, CH2 1.80, m
1.23, m
13 30.1, CH2 1.98, m 30.1, CH2 1.98, m 30.1, CH2 1.97, m
1.89, dd
(4.8,
12.0)
1.90, m 1.90, dd
(4.8, 12.0)
14 134.9, C 134.8, C 134.9, C
15 121.6, CH 6.09, d
(3.0)
121.7, CH 6.09, s 121.6, CH 6.09, d
(4.8)
16 23.8, CH3 1.67, s 23.8, CH3 1.68, s 23.8, CH3 1.67, s
17 35.7, CH2 2.71, dd
(5.4, 8.4)
35.9, CH2 2.70, dd
(6.6, 7.8)
35.8, CH2 2.71, dd
(4.8, 9.0)
2.49, dd
(4.8, 9.0)
2.49, m 2.50, dd
(4.8, 9.0)
18 120.3, CH 4.77, m 120.2, CH 4.77, m 120.2, CH 4.76, m
19 133.6, C 133.6, C 133.6, C
20 25.9, CH3 1.53, s 25.9, CH3 1.54, s 25.84, CH3 1.54, s
21 18.3, CH3 1.59, s 18.3, CH3 1.59, s 18.3, CH3 1.60, s
22 25.78, CH3 1.25, s 25.66, CH3 1.25, s 25.80, CH3 1.25, s
1′ 207.2, C 206.8, C 202.8, C
2′ 35.4, CH 3.97, sept
(6.6, 7.2)
41.7, CH 3.83, m 41.7, CH 2.97, m
3′ 19.0, CH3 1.11, d
(6.6)
16.4, CH3 1.09, d
(6.6)
18.9, CH3 1.66, m
4′ 19.4, CH3 1.17, d
(6.6)
27.0, CH2 1.80, m 14.3, CH3 1.00, t
(7.2)
5′ 12.0, CH3 0.96, t
(7.8)
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1.59 (H3-21) and δH 1.40 (H3-10)/1.80 (Hb-12) suggested the same
orientation of Me-10 and the isoprenyl group at C-5 (Fig. 2).
There was the presence of another minor tautomer (1′) due to the
keto-enol tautomerism of the enol-β-triketone moiety. The NMR data of
1′ were similar to 1, except for the location of the OH group. In the
HMBC spectrum of 1′, the active proton (δH 18.39) was correlated to C-
1 (δc 110.4), C-5 (δc 47.8), and C-6 (δC 197.3), which located the po-
sition of the OH group at C-6. Due to the phenomenon of keto-enol
tautomerism, the NMR data of 1 were recorded in different solvents,
including CDCl3, CD3OD, acetone-d6, DMSO‑d6, and acetonitrile-d3. As a
result, the ratios of the two tautomers (1: 1′) were approximately
1:0.23, 1:0.28, 1:0.17, 1:0.20 and 1:0.17 in the CDCl3, CD3OD, acetone-
d6, DMSO‑d6, and acetonitrile-d3, respectively (supporting information).
The ratio of the major tautomer (1) was larger in acetone-d6, DMSO‑d6
and acetonitrile-d3 than in CDCl3 and CD3OD. The ECD curve of 1 was
recorded in acetonitrile, the tautomer (1) was the main component. The
absolute configurations of 1 were assigned by comparison of the ex-
perimental and the calculated electronic circular dichroism (ECD)
spectra. Due to the presence of minor tautomer (1′), the theoretical ECD
calculation was conducted in acetonitrile using time-dependent density
functional theory (TD-DFT) at the B3LYP/6–31 + g (d, p) level for the
low energy conformers of the two tautomers (5R,7S,8R)-1 and
(5R,7S,8R)-1′. The ECD spectrum of (5R,7S,8R)-1 and fitted ECD curve
of two tautomers [(5R,7S,8R)-1 and (5R,7S,8R)-1′] were generated
using the program SpecDis 1.6 (University of Würzburg, Würzburg,
Germany) and GraphPad Prism 5 (University of California San Diego,
USA) from dipole-length rotational strengths by applying Gaussian
band shapes with sigma = 0.3 eV. As a result, the overall experimental
ECD curve of 1 matched well with the calculated ECD spectrum of
(5R,7S,8R)-1 as well as the fitted spectrum of two tautomers
[(5R,7S,8R)-1 and (5R,7S,8R)-1′] (Fig. 3). Thus, the minor tautomer
contributed slightly to the ECD spectrum of 1. Consequently, the ab-
solute configurations of 1 were assigned as 5R,7S,8R.
Hyperelodione B (2) was isolated as a yellowish oil with the mo-
lecular formula C27H38O4 revealed by its HRESIMS [M+H]+ ion signal
at m/z 427.2846 [M+H]+ (calcd. for C27H39O4, 427.2843), requiring
nine indices of hydrogen deficiency. The IR spectrum of 2 (1656,
3631 cm−1) indicated the presence of carbonyl and hydroxyl groups.
The 13C NMR data of 2 were similar to those of 1 except for the iso-
propyl group was replaced by a sec-butyl group in 2, as assigned by the
HMBC correlations from δH 1.09 (Me-3′) to δC 206.8 (C-1′)/δC 41.7 (C-
2′)/δC 27.0 (C-4′) and from δH 0.96 (Me-5′) to C-2′/C-4′ (Fig. 2). Thus,
the 2D structure of 2 was elucidated. The NOESY correlations of 2 were
similar to 1, which resulted in the same relative configuration (Fig. 2).
The absolute configuration of the chiral center in the α-methylbutyryl
group can be determined on the basis of optical rotation data by the
means of Brewster's rule of atomic asymmetry (Pei et al., 1989). Ac-
cording to this rule, if the absolute configuration of the chiral center in
the α-methylbutyryl group is S, the optical value will be dextrorotation
(+). The optical rotation value of 2 ( α[ ]D28+26.3) was opposite that of 1
( α[ ]D28–18.6), which assigned the absolute configuration of C-2′ as S.
Furthermore, the absolute configuration of the α-methylbutyryl group
in the reported analogues hyperjapone C and E from the same genus
were unambiguously determined as S by the X-ray analysis (Yang et al.,
2016). Thus, based on the biogenesis relationship, the absolute con-
figuration of C-2′ can be further confirmed as S. Moreover, the
Fig. 2. Key HMBC, 1H–1H COSY and NOESY correlations of compounds 1–3.
Fig. 3. Calculated and experimental ECD spectra of 1 and two tautomers.
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experimental ECD data of 2 had a high degree of similarity to that of the
biogenetically related 1 (Fig. 3). Another minor tautomer with an OH
group at C-6 also existed for 2, which contributed little influence on the
CD spectrum of 2 (Fig. 4). Thus, the absolute configurations of the
chiral carbons in 2 were defined as 2′S,5R,7S,8R.
Hyperelodione C (3), a yellowish oil, was assigned the molecular
formula of C26H36O4 via 13C NMR and HRESIMS data with an [M+H]+
ion at m/z 413.2678 (calcd. for C26H37O4, 413.2686), which accounted
for nine indices of hydrogen deficiency. The IR absorptions at 3449 and
1651 cm−1 also indicated the presence of carbonyl and hydroxyl
groups. The 13C NMR data of 3 were identical to those of 1 except for an
n-propyl group substituent at C-1′ instead of an isopropyl group, which
was further confirmed by the HMBC and 1H–1H COSY data (Fig. 2). The
relative configuration of 3 was also determined by the NOESY corre-
lations, which resulted in the same configuration as that of 1 and 2
(Fig. 2). There was also another minor tautomer with the OH group at
C-6 as in 1 and 2, which slightly influenced the CD curve. The experi-
mental ECD data of 3 well to that of the biogenetically related 1
(Fig. 4), which allowed the assignment of the same absolute config-
uration of 5R,7S,8R.
The putative biogenetic pathway of 1–3 was proposed (Scheme 1).
The structures of 1–3 were proposed to derive from the isobutyryl-CoA
(i), α-methylbutyryl-CoA (ii), and butyryl-CoA (iii), respectively. Then,
further condensation with three malonyl-CoAs formed the acylphlor-
oglucinol core through the represented polyketide-type biosynthesis
pathway (Abe et al., 2004). The acylphloroglucinol core was further
prenylated and methylated to afford monocyclic polyprenylated
acylphloroglucinols (MPAPs) (Ciochina and Grossman, 2006). Finally,
compounds 1–3 were putatively biosynthesized from MPAPs through a
series of reactions involving epoxidation, intramolecular cyclization,
dehydration and reduction (Hu et al., 2000; Tian et al., 2014b).
2.2. The interaction between RXRα-LBD and compounds 1–3
RXRα, a crucial member of the nuclear receptor superfamily, is a
ligand-dependent transcription factor. RXRα regulates biological pro-
cesses such as cell differentiation, proliferation and apoptosis through
the interaction with small-molecule modulators. RXRα possesses the
classical functional domains of nuclear receptors, including a DNA-
binding domain (DBD) and a ligand-binding domain (LBD) (Altucci
et al., 2007). Many natural products have been demonstrated to bind to
the RXRα-LBD to modulate the genomic or nongenomic function of
RXRα. In this study, the interactions between the RXRα-LBD and the
compounds were investigated by fluorescence quenching technology, a
method that measures the fluorescence quenching caused by a ligand
binding to the protein. Gradual fluorescence quenching was observed
when RXRα-LBD was exposed to increasing concentration of the new
compounds 1–3 (Fig. 5). The results showed that the binding constants
(KD values) of compounds 1 and 2 to the RXRα-LBD were fitted as 47.01
μΜ and 32.50 μΜ, respectively, while compound 3 could bind to RXRα-
LBD with a KD of 12.81 μΜ. These data indicated that compounds 1–3
have the potential to bind to RXRα, while compound 3 showed a
stronger interaction with the RXRα-LBD than the other two compounds.
2.3. The RXRα transactivation effects of compounds 1–3
As a nuclear receptor, RXRα has genomic functions via transacti-
vation. The effects of compounds 1–3 on RXRα transactivation were
examined by dual-luciferase reporter gene assay. As shown in Fig. 5, all
the compounds inhibited 9-cis-RA-induced RXRα transactivation at
concentrations of 12.5 μΜ and 25 μΜ, while compound 3 exhibited
Fig. 4. Experimental ECD spectra of 1–3.
Scheme 1. Plausible Biogenetic Pathway of 1–3.
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better inhibitory activity than the other two compounds at the same
concentrations (Fig. 6).
2.4. Growth inhibitory activities of compounds 1–3 on MCF-7 and HeLa
cells
The growth inhibitory effects of compounds 1–3 on the human
cervical cancer cell line (HeLa) and human breast cancer cell line (MCF-
7) were examined. As a result, all the compounds exhibited cytotoxic
effects on these two cancer cell lines in a dose-dependent manner
(Fig. 7). Among them, compound 3 showed the most potent growth
inhibitory effects on the HeLa and MCF-7 cell lines with IC50 values of
24.39 and 26.33 μΜ, respectively, while the IC50 values of compound 1
on these two cancer cells were 37.80 and 44.37 μΜ, and the IC50 values
of compound 2 were 51.44 and 61.66 μΜ, respectively. The above data
suggested that compound 3 displayed potent anti-proliferative activity
against HeLa and MCF-7 cells, while compounds 1 and 2 had moderate
cytotoxic activities.
2.5. Induction of PARP cleavage by compound 3
To investigate whether compound 3 induces cancer cell apoptosis,
HeLa and MCF-7 cells were incubated with increasing concentrations
(10–30 μM) of compound 3 for 48 h. Cleaved poly (ADP-ribose)
polymerase (PARP), a typical apoptotic marker in the apoptotic re-
sponse, was measured via Western blot. As a result, 3 induced HeLa and
MCF-7 cell apoptosis with a dose dependent PARP cleavage (Fig. 8).
Thus, compound 3 could potentially induce HeLa cells and MCF-7 cell
apoptosis.
2.6. Molecular docking of 1–3 to RXRα-LBD
Molecular docking is an effective way to preliminarily understand
the structure-activity relationship (SAR) by exploring the interaction
mode between a compound and the targeted protein. In this study, a
molecular docking technique was used to predict the interaction be-
tween compounds 1–3 and the RXRα-LBD protein with Molecular
Operating Environment (MOE) (2009.10) software. As a result, the
Fig. 5. The interaction between RXRα-LBD and compounds. After treated with compounds 1–3, the binding affinity of compound toward RXRα-LBD was measured
via fluorescence quenching technology at 298 K.
Fig. 6. The RXRα transactivation effects of compounds. 293T cells were treated
with different concentrations of new compounds (0, 12.5, 25 μΜ), the trans-
activation activities of reporter gene for RXRα were measured by dual-luci-
ferase reporter gene assay. The values are the mean ± SD for four independent
replicates (*p < 0.05, **p < 0.01, compared with cells treated with 9-cis-RA
alone).
Fig. 7. Cytotoxic effects of compounds 1–3. HeLa and MCF-7 cells were exposed
to various concentrations of compounds 1–3 (0, 3.125, 6.25, 12.5, 25, 50 μΜ).
After 48 h, cytotoxic activities of compounds against cancer cells were mea-
sured by MTT assay. The values are the mean ± SD for four independent
replicates.
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carbonyl group at C-6 of 1 and the hydroxyl group at C-2 of 2 could
interact with Lys440 in the RXRα-LBD protein, while the carbonyl
group at C-1′ of 3 could bind to the Gln275 of RXRα-LBD with a dif-
ferent interaction mode (Fig. 9). The predicted binding sites of 1–3 to
RXRα-LBD were quite different from the traditional ligands which
usually bind to Arg316 of the RXRα-LBD, such as for 9-cis-retinoic acid.
A preliminary SAR study was performed by extensive analysis of the
structure and bioactivity. Compounds 1–3 possess the common mono-
terpenoid polyprenylated acylphloroglucinol skeleton with a 6/6/6
fused tricyclic system, while the only difference lies in the substituents
at C-1′. Contrasting the activity results of compounds 1–3, it was ob-
served that 3, with an n-propyl group at C-1′, showed more potent ef-
fects than compounds 1 and 2, with an isopropyl group and a sec-butyl
group at C-1′, respectively. Based on the above analysis, the n-propyl
group at C-1′ in this type of compound is helpful for the RXRα related
activities, which was confirmed by the molecular docking results in
which 3 could bind to the Gln275 of the RXRα-LBD in a different in-
teraction modes compared with 1 and 2. Due to the limited quantities of
the isolates, the thorough SAR needs further discussion.
3. Conclusion
In summary, three undescribed monoterpenoid polyprenylated
acylphloroglucinols possessing a 6/6/6 fused tricyclic system, hyper-
elodiones A-C (1–3), were obtained from H. elodeoides. The mono-
terpenoid fragments in 1–3 were predicted to be biosynthesized by an
isopentenyl at C-3 that formed a dihydropyran ring with the 4-OH of
the core structure and another lateral prenyl group located at C-8 that
cyclized into a six-membered ring by the carbon–carbon bond forma-
tion between C-5 and C-7. This was quite different from the reported
monoterpenoid polyprenylated acylphloroglucinols, which were cy-
clized by a geranyl group (two prenyl groups linked from head to tail)
at C-3. The phenomenon of keto-enol tautomerism existed in these
monoterpenoid polyprenylated acylphloroglucinols. The major tau-
tomer, with OH group at C-2, contributed in a high proportion and
might due to the pseudo six-membered heterocyclic ring formed by
Fig. 8. PARP cleavage induction by compound 3. HeLa cells and MCF-7 cells were treated with different concentrations of compound 3 (0, 10, 20, 30 μΜ) for 48 h.
The level of cleaved PARP was analyzed by Western blot.
Fig. 9. Molecular docking of compounds 1–3 toward RXRα-LBD. (A) Docking of 1 to RXRα-LBD. (B) Docking of 2 to RXRα-LBD. (C) Docking of 3 to RXRα-LBD. (D)
Binding site of 1 to the RXRα-LBD. (E) Binding site of 2 to the RXRα-LBD. (F) Binding site of 3 to the RXRα-LBD.
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strong intramolecular hydrogen bonding between the active hydrogen
and O-2′. The absolute configuration of 1 was assigned by the com-
parison of experimental and calculated ECD data, while the absolute
configurations of 2 and 3 were assigned to be the same as 1 by their
similar experimental ECD spectra and common biosynthetic origin. In
addition, the putative biogenetic pathway of 1–3 was proposed. A
fluorescence quenching assay suggested that 1–3 could bind to RXRα-
LBD, whereas 3 showed the strongest interaction with a KD of 12.81 μΜ.
In addition, compounds 1–3 inhibited 9-cis-RA-induced RXRα transac-
tivation and the growth of HeLa and MCF-7 cell lines in a dose-de-
pendent manner, while 3 showed the most potent inhibitory activities.
Western-blot assays showed dose-dependent PARP cleavage when HeLa
cells and MCF-7 cells were exposed to 3. Molecular docking results
suggested that 3 with an n-propyl group could interact with the Gln275
moiety of RXRα-LBD, which was quite different from the interaction
mode of 1 and 2. Thus, 3 can be considered a promising lead compound
for cancer therapy, which can bind to the RXRα-LBD and induce HeLa
and MCF-7 cell apoptosis.
4. Experimental
4.1. General experimental procedures
Optical rotations were measured by using a Rudolph Autopol IV/IV-
T polarimeter (NJ, USA). UV data were recorded on an UV-2600 UV/Vis
spectrometer (Shimadzu, Japan). CD spectra were measured on a
Chirascan spectropolarimeter (Applied Photophysics, UK). NMR spectra
were conducted on a Bruker AVANCE III 600 MHz spectrometer
(Bruker, Germany). High-resolution electrospray ionization mass
spectra (HR-ESI-MS) were acquired by using a Thermo Fisher Q
Exactive mass spectrometer (Thermo, USA). HPLC separations were
performed with a Shimadzu LC-8A Liquid Chromatography system
equipped with a DAD (Shimadzu, Japan). YMC (RP)-18 column (5 μm,
10 × 250 mm; YMC, Japan) were performed for reversed phase
semipreparative separations. Silica gel (Qingdao Marine Chemical Ltd.,
China) and Sephadex LH-20 (Amersham Pharmacia Biotech, Sweden)
were used for open column chromatography separations. Analytical
thin-layer chromatography (TLC) separations were performed on silica
gel GF254 plates (Qingdao Marine Chemical Inc., China).
4.2. Plant material
The whole plants of Hypericum elodeoides Choisy (wet) were col-
lected from Ningde city, Fujian Province, China, in September 2016.
They were authenticated by Prof. Zhen-Ji Li (College of the
Environment & Ecology, Xiamen University). A voucher specimen (HE-
201609) was deposited at the School of Pharmaceutical Sciences,
Xiamen University.
4.3. Extraction and isolation
The dried and powdered whole plants of H. elodeoides (12.9 kg)
were soaked overnight in 95% aqueous EtOH (4 × 100 L) at room
temperature and then refluxed four times in 95% EtOH for 3 h each
time. Concentration of the filtrate in vacuo to yielded the crude extract
(949.7 g). The extract was suspended in water and partitioned con-
secutively with petroleum ether. The petroleum ether extract (150.7 g)
was subjected to silica gel column chromatography (CC) eluted with a
gradient of cyclohexane−EtOAc (1:0, 50:1, 25:1, 10:1, 5:1, 2:1, 1:1,
0:1) to afford eight fractions (Fr. a1−Fr. a8). Fr. a3 (29.5 g) was further
refined by silica gel CC eluted with petroleum ether−EtOAc (1:0,
400:1, 200:1, 100:1, 50:1, 25:1, 0:1) to afford eight fractions (Fr.
a3A−Fr. a3H). Fr. a3E (9.9 g) was subsequently subjected to silica gel
CC eluted with petroleum ether−acetone (200:1, 150:1, 100:1, 15:1,
0:1) to give six fractions (Fr. a3E1−Fr. a3E6). Fr. a3E4 (5.8 g) was
fractionated by silica gel CC eluted with cyclohexane−EtOAc (1:0,
1000:1, 500:1, 250:1, 100:1, 15:1, 0:1) to give five fractions (Fr.
a3E4A−Fr. a3E4E). Finally, compound 2 (4.5 mg) was successfully
separated by repeated prep-HPLC with MeOH–H2O (97:3) at a flow rate
of 5 mL/min, from Fr. a3E4C. Furthermore, Fr. a3E4D was purified by
repeated prep-HPLC with 95% MeOH–H2O at a flow rate of 5 mL/min,
to yield compounds 1 (4.9 mg) and 3 (8.8 mg).
Hyperelodione A (1): yellowish oil; α[ ]D28 –18.6 (c 0.43, CH3OH);
UV (CH3OH) λmax (log ε) 202 (4.06), 228 (3.98), 244 (4.00), 326 (3.82)
nm; ECD (ACN) λmax (Δε) 198 (0.13), 239 (0.01), 313 (0.31) nm; IR
(KBr)νmax 3581, 2979, 2361, 1697, 1652, 1381, 1116, 974 cm−1; 1H
and 13C NMR data, see Table 1; HRESIMS m/z 413.2695 [M+H]+
(cacld for C26H37O4, 413.2686).
Hyperelodione B (2): yellowish oil; α[ ]D28 +26.3 (c 0.35, CH3OH);
UV (CH3OH) λmax (log ε) 201 (3.78), 244 (3.74) nm; ECD (ACN) λmax
(Δε) 198 (0.13), 237 (0.04), 313 (0.20) nm; IR (KBr)νmax 3631, 2977,
2314, 1656, 1526, 1458, 1211, 1127 cm−1; 1H and 13C NMR data, see
Table 1; HRESIMS m/z 427.2846 [M+H]+ (cacld for C27H39O4,
427.2843).
Hyperelodione C (3): yellowish oil; α[ ]D28 –23.0 (c 0.66, CH3OH);
UV (CH3OH) λmax (log ε) 201 (4.12), 227 (4.02), 243 (4.03), 324 (3.87)
nm; ECD (ACN) λmax (Δε) 186 (−0.02), 243 (0.26), 322 (0.28) nm; IR
(KBr)νmax 3449, 2926, 2359, 1651, 1529, 1458, 1119 cm−1; 1H and 13C
NMR data, see Table 1; HRESIMS m/z 413.2678 [M+H]+ (cacld for
C26H37O4, 413.2686).
4.4. RXRα-LBD purified protein
Human RXRα-LBD (223–462) was cloned as an N-terminal histi-
dine-tagged fusion protein in the pET-15b vector and overexpressed in
E. coli BL21 (DE3). After centrifugation, resuspension and sonication,
the extract was incubated with the His60 Ni Superflow resin for 4 h.
The combined protein was purified by a Ni2+-NTA agarose column at
low temperatures.
4.5. Fluorescence measurements
Fluorescence measurements were performed on a Cary Eclipse
Fluorescence spectrophotometer (Varian) in a 10 mm quartz cuvette.
The 1 mM concentration of RXRα-LBD was incubated with different
concentrations of compounds. The protein was excited at 280 nm and
the fluorescence spectra between 290 nm and 500 nm were measured
with the a spectrophotometer at RT. The data were analyzed by Origin
2017.
4.6. Luciferease report assay
First, 293T cells were transfected with plasmids combined with
10 μg/mL pGL5 luciferase reporter vector and 4 μg/mL pBIND- RXRα-
LBD vector. After 12 h, cells were treated with different concentrations
of compounds for 12 h and then lysed by PLB on an oscillating platform
for 20 min. Firefly luciferase (FL) and Renilla luciferase (RL) activities
were analyzed with the Dual-Luciferase Reporter Assay system
(Promega).
= ×Relative luciferase activity (%) FL/RL 100%
4.7. Cytotoxicity assay
HeLa cells and MCF-7 cells were seeded into 96-well plates at a
density of 5 × 103 cells per well. After 12 h, cells were treated with
different concentrations of compounds. After incubation for 48 h, 15 μL
of MTT reagent and 60 μL of MEM (HeLa) or DMEM (MCF-7) was added
and the cells were cultured for 4 h. After removing the supernatant, the
transformed crystals were dissolved in DMSO (100 μL) and measured at
490 nm using a microplate reader (Thermo Multiskan MK3, Thermo
Scientific, Helsinki, Finland). The cell proliferation-inhibition rate (%)
D. Qiu, et al. Phytochemistry 170 (2020) 112216
7
was calculated as follows:
−
− ×
Growth Rate (%)[(ODsample ODblank)/(ODcontrol
ODblank)] 100%
4.8. Western blotting
Equal amounts of the cell lysates were electrophoresed on a 10%
SDS-PAGE gel and transferred to nitrocellulose. The membranes were
blocked with 5% nonfat milk in TBST buffer (10 mM Tris–HCl [pH 8.0],
150 mM NaCl, and 0.05% Tween 20) at RT. After 1 h, the membranes
were incubated with various primary antibodies at 4 °C overnight. After
washing three times with TBST, the membranes were detected with
either anti-mouse (1:3000) or anti-rabbit (1:3000) antibodies for 1 h
and washed four times. The final immunoreactive products were vi-
sualized by using an enhanced chemiluminescence system.
4.9. Molecular docking studies
Molecular docking studies of compounds bound to RXRα-LBD were
performed with MOE (2009.10) software. Compounds were imported
into the MOE database in.sdf format which were further optimized via
partial charge, energy minimization, and geometry optimization
(Rebuild 3D) with a root-mean-square gradient of 0.01 and saved in
the.mdb database format. The 3D structure of RXRα-LBD (https://doi.
org/10.2210/pdb4zsh) was downloaded from the Research
Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB
PDB). For the docking process, the “Triangle Matcher” placement
method and London dG scoring function were selected, and the results
were further refined by the force field method. Molecular docking si-
mulations of compounds 1–3 with RXRα-LBD were conducted for 30
times, and the London dG scoring system was used to select the best
interactions based on the smallest E_score2 provided.
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